MetLife, Inc.
Michel Khalaf (President & CEO) sells MET shares
AI-generated summary
President & CEO, Director Michel Khalaf acquired 248,729 shares of common stock through derivative exercises for a total value of $11,475,677.59. Michel Khalaf also sold 187,425 shares of common stock in an open-market sale for a total value of $19,298,702.43. Following these transactions, Michel Khalaf directly held 759,013 shares of common stock.
Key facts
- Insider
- Michel Khalaf · President & CEO, Director
| Date | Transaction | Shares | Price | Value | Held after | Ownership |
|---|---|---|---|---|---|---|
| Nov 10, 2026 | M · exercise or conversion of a derivative | +28,817 | $46.85 | $1,350,076.45 | 726,526 | Direct |
| Nov 10, 2026 | M · exercise or conversion of a derivative | +34,608 | $45.50 | $1,574,664.00 | 761,134 | Direct |
| Nov 10, 2026 | M · exercise or conversion of a derivative | +90,726 | $44.65 | $4,050,915.90 | 851,860 | Direct |
| Nov 10, 2026 | M · exercise or conversion of a derivative | +94,578 | $47.58 | $4,500,021.24 | 946,438 | Direct |
| Nov 10, 2026 | S · open-market saleFootnotes F1, F2 | −187,425 | $102.97 | $19,298,702.43 | 759,013 | Direct |
| Nov 10, 2026 | M · exercise or conversion of a derivativeEmployee Stock Option (Right to Buy)Footnotes F3, F4 | −28,817 | $0.00 | $0.00 | 0 | Direct |
| Nov 10, 2026 | M · exercise or conversion of a derivativeEmployee Stock Option (Right to Buy)Footnotes F5 | −34,608 | $0.00 | $0.00 | 0 | Direct |
| Nov 10, 2026 | M · exercise or conversion of a derivativeEmployee Stock Option (Right to Buy)Footnotes F6 | −90,726 | $0.00 | $0.00 | 0 | Direct |
| Nov 10, 2026 | M · exercise or conversion of a derivativeEmployee Stock Option (Right to Buy)Footnotes F7 | −94,578 | $0.00 | $0.00 | 0 | Direct |
Footnotes
- F1 The reporting person sold only the number of shares of MetLife, Inc.'s common stock necessary to pay the exercise price of the options exercised on November 10, 2026, and related tax obligations and fees.
- F2 The price reported is the weighted average price of the aggregate number of shares sold in multiple open market transactions. The shares were sold at prices between $102.59 to $103.235, inclusive. The reporting person undertakes to provide to the staff of the SEC, MetLife, Inc., or a security holder of the Issuer, upon request, full information regarding the number of shares purchased at each separate price.
- F3 Includes 3,073 stock options previously added to the reporting person's award through an adjustment to maintain the intrinsic value of the stock options in light of the distribution by MetLife, Inc. to its shareholders of Brighthouse Financial, Inc. common stock. The reporting person did not receive shares of Brighthouse Financial, Inc. common stock on account of the stock options.
- F4 The options became exercisable in three equal installments on February 28, 2018, 2019, and 2020.
- F5 The options became exercisable in three installments on March 2, 2019, 2020 and 2021.
- F6 The options became exercisable in three installments on February 26, 2020, 2021 and 2022.
- F7 The options become exercisable in equal installments on each of the first three anniversaries of the grant date.
More MET filings
- SC 13G/A
Filed Nov 12, 2026
- 144
Filed Nov 10, 2026
- 8-K
Filed Nov 9, 2026
- SC 13D/A
Filed Nov 5, 2026
- 10-Q
Filed Nov 5, 2026
- 8-K
Filed Nov 4, 2026
Not investment advice. Summaries can contain errors; the SEC filing is the official record.